Cheng, K. W., Wong, C. C., Alston, N., Mackenzie, G. G., Huang, L., Ouyang, N., . . . Rigas, B. (2013).,
Aerosol administration of phospho-sulindac inhibits lung tumorigenesis., Molecular Cancer Therapeutics, 12(8), 1417-1428. doi:10.1158/1535-7163.MCT-13-0006-T [doi]
Muscella, A., Vetrugno, C., Migoni, D., Biagioni, F., Fanizzi, F. P., Fornai, F., . . . Marsigliante, S. (2014).,
Antitumor activity of [pt(O,O'-acac)(gamma-acac)(DMS)] in mouse xenograft model of breast cancer., Cell Death & Disease, 5, e1014. doi:10.1038/cddis.2013.554 [doi]
Mertens-Talcott, S. U., Noratto, G. D., Li, X., Angel-Morales, G., Bertoldi, M. C., & Safe, S. (2013).,
Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: Role of sp transcription factors and microRNA-27a:ZBTB10., Molecular Carcinogenesis, 52(8), 591-602. doi:10.1002/mc.21893 [doi]
Johnson, T. J., Hoti, N., Liu, C., Chowdhury, W. H., Li, Y., Zhang, Y., . . . Rodriguez, R. (2013).,
Bicalutamide-activated oncolytic adenovirus for the adjuvant therapy of high-risk prostate cancer., Cancer Gene Therapy, 20(7), 394-402. doi:10.1038/cgt.2013.34 [doi]
Accardo, A., Mansi, R., Salzano, G., Morisco, A., Aurilio, M., Parisi, A., . . . Morelli, G. (2012).,
Bombesin peptide antagonist for target-selective delivery of liposomal doxorubicin on cancer cells., Journal of Drug Targeting, doi:10.3109/1061186X.2012.741138 [doi]
Tuscano, J. M., Kato, J., Pearson, D., Xiong, C., Newell, L., Ma, Y., . . . O'Donnell, R. T. (2012).,
CD22 antigen is broadly expressed on lung cancer cells and is a target for antibody-based therapy., Cancer Research, 72(21), 5556-5565. doi:10.1158/0008-5472.CAN-12-0173 [doi]
Schmid, D., Fay, F., Small, D. M., Jaworski, J., Riley, J. S., Tegazzini, D., . . . Scott, C. J. (2014).,
Efficient drug delivery and induction of apoptosis in colorectal tumors using a death receptor 5-targeted nanomedicine., Molecular Therapy : The Journal of the American Society of Gene Therapy, 22(12), 2083-2092. doi:10.1038/mt.2014.137 [doi]
Tome-Amat, J., Olombrada, M., Ruiz-de-la-Herran, J., Perez-Gomez, E., Andradas, C., Sanchez, C., . . . Lacadena, J. (2015).,
Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin alpha-sarcin in nude mice bearing human colorectal cancer xenografts., Springerplus, 4, 168-015-0943-5. eCollection 2015. doi:10.1186/s40064-015-0943-5 [doi]
Gundala, S. R., Mukkavilli, R., Yang, C., Yadav, P., Tandon, V., Vangala, S., . . . Aneja, R. (2014).,
Enterohepatic recirculation of bioactive ginger phytochemicals is associated with enhanced tumor growth-inhibitory activity of ginger extract., Carcinogenesis, 35(6), 1320-1329. doi:10.1093/carcin/bgu011 [doi]
Chen, C., Constantinou, A., Chester, K. A., Vyas, B., Canis, K., Haslam, S. M., . . . Deonarain, M. P. (2012).,
Glycoengineering approach to half-life extension of recombinant biotherapeutics., Bioconjugate Chemistry, 23(8), 1524-1533. doi:10.1021/bc200624a [doi]
Gundala, S. R., Yang, C., Mukkavilli, R., Paranjpe, R., Brahmbhatt, M., Pannu, V., . . . Aneja, R. (2014).,
Hydroxychavicol, a betel leaf component, inhibits prostate cancer through ROS-driven DNA damage and apoptosis., Toxicology and Applied Pharmacology, 280(1), 86-96. doi:10.1016/j.taap.2014.07.012 [doi]
Cho, E. J., Sun, B., Doh, K. O., Wilson, E. M., Torregrosa-Allen, S., Elzey, B. D., & Yeo, Y. (2015).,
Intraperitoneal delivery of platinum with in-situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer., Biomaterials, 37, 312-319. doi:10.1016/j.biomaterials.2014.10.039 [doi]
Ganapathy, S., Xiao, S., Seo, S. J., Lall, R., Yang, M., Xu, T., . . . Yuan, Z. M. (2014).,
Low-dose arsenic induces chemotherapy protection via p53/NF-kappaB-mediated metabolic regulation., Oncogene, 33(11), 1359-1366. doi:10.1038/onc.2013.81 [doi]
Banerjee, N., Kim, H., Krenek, K., Talcott, S. T., & Mertens-Talcott, S. U. (2015).,
Mango polyphenolics suppressed tumor growth in breast cancer xenografts in mice: Role of the PI3K/AKT pathway and associated microRNAs., Nutrition Research (New York, N.Y.), 35(8), 744-751. doi:10.1016/j.nutres.2015.06.002 [doi]
Wong, H. H., Jiang, G., Gangeswaran, R., Wang, P., Wang, J., Yuan, M., . . . Wang, Y. (2012).,
Modification of the early gene enhancer-promoter improves the oncolytic potency of adenovirus 11., Molecular Therapy : The Journal of the American Society of Gene Therapy, 20(2), 306-316. doi:10.1038/mt.2011.242 [doi]
Mu, Z., Ma, C. M., Chen, X., Cvetkovic, D., Pollack, A., & Chen, L. (2012).,
MR-guided pulsed high intensity focused ultrasound enhancement of docetaxel combined with radiotherapy for prostate cancer treatment., Physics in Medicine and Biology, 57(2), 535-545. doi:10.1088/0031-9155/57/2/535 [doi]
Wang, C. Z., Zhang, Z., Anderson, S., & Yuan, C. S. (2014).,
Natural products and chemotherapeutic agents on cancer: Prevention vs. treatment., The American Journal of Chinese Medicine, 42(6), 1555-1558. doi:10.1142/S0192415X1420002X [doi]
Accardo, A., Salsano, G., Morisco, A., Aurilio, M., Parisi, A., Maione, F., . . . Morelli, G. (2012).,
Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: A potential theranostic agent., International Journal of Nanomedicine, 7, 2007-2017. doi:10.2147/IJN.S29242 [doi]
Gundala, S. R., Yang, C., Lakshminarayana, N., Asif, G., Gupta, M. V., Shamsi, S., & Aneja, R. (2013).,
Polar biophenolics in sweet potato greens extract synergize to inhibit prostate cancer cell proliferation and in vivo tumor growth., Carcinogenesis, 34(9), 2039-2049. doi:10.1093/carcin/bgt141 [doi]
Wang, C. Z., Zhang, Z., Wan, J. Y., Zhang, C. F., Anderson, S., He, X., . . . Yuan, C. S. (2015).,
Protopanaxadiol, an active ginseng metabolite, significantly enhances the effects of fluorouracil on colon cancer., Nutrients, 7(2), 799-814. doi:10.3390/nu7020799 [doi]
Xu, W., Liu, L., Brown, N. J., Christian, S., & Hornby, D. (2012).,
Quantum dot-conjugated anti-GRP78 scFv inhibits cancer growth in mice., Molecules (Basel, Switzerland), 17(1), 796-808. doi:10.3390/molecules17010796 [doi]
Saelen, M. G., Ree, A. H., Kristian, A., Fleten, K. G., Furre, T., Hektoen, H. H., & Flatmark, K. (2012).,
Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma., Radiation Oncology (London, England), 7, 165-717X-7-165. doi:10.1186/1748-717X-7-165 [doi]
Pozzi, V., Sartini, D., Morganti, S., Giuliante, R., Di Ruscio, G., Santarelli, A., . . . Emanuelli, M. (2013).,
RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells., PloS One, 8(8), e71272. doi:10.1371/journal.pone.0071272 [doi]
Fokas, E., Prevo, R., Pollard, J. R., Reaper, P. M., Charlton, P. A., Cornelissen, B., . . . Brunner, T. B. (2012).,
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation., Cell Death & Disease, 3, e441. doi:10.1038/cddis.2012.181 [doi]
Jin, H. R., Zhao, J., Zhang, Z., Liao, Y., Wang, C. Z., Huang, W. H., . . . Du, W. (2012).,
The antitumor natural compound falcarindiol promotes cancer cell death by inducing endoplasmic reticulum stress., Cell Death & Disease, 3, e376. doi:10.1038/cddis.2012.122 [doi]
Solodeev, I., Zahalka, M. A., & Moroz, C. (2014).,
The novel C24D synthetic polypeptide inhibits binding of placenta immunosuppressive ferritin to human T cells and elicits anti-breast cancer immunity in vitro and in vivo., Neoplasia (New York, N.Y.), 16(9), 741-750. doi:10.1016/j.neo.2014.08.005 [doi]
Zhou, H., Ekmekcioglu, S., Marks, J. W., Mohamedali, K. A., Asrani, K., Phillips, K. K., . . . Rosenblum, M. G. (2013).,
The TWEAK receptor Fn14 is a therapeutic target in melanoma: Immunotoxins targeting Fn14 receptor for malignant melanoma treatment., The Journal of Investigative Dermatology, 133(4), 1052-1062. doi:10.1038/jid.2012.402 [doi]
